Today, effective partnerships with patient leaders are more important than ever! Don’t miss your chance to learn from patient, policy, and industry leaders in a highly innovative training format designed specifically for today’s virtual environment. Not just for rare diseases, CORD’s Patient Partners Leadership Training program in-person (virtual) sessions start on Friday, September 18, 2020 and will run bi-weekly until Friday, February 5, 2021 and is limited to 30 participants. Speakers include international and Canadian experts from government, research, industry, and patient organizations.
Who? Patient Advocates and Patient Partner Leaders from industry and other sectors who are interested in engaging as equal partners in exploration, discovery, and creation of roles as leaders in all phases of the drug lifecycle. Limited to 30 participants.
What? This program will enhance the capabilities of patients, patient advocates, and various stakeholder groups that are involved in drug development and access to partner effectively throughout all phases of the drug lifecycle from drug development to real-world management. New modules have been added to the overview.
Where? Virtual, 2-hour live sessions (bi-weekly) with interactive small group capabilities that will include structured opportunities comprised of expert presentations from multiple sectors and post-session discussions and written assignments.
Why? Partnering with patients has transformed how drugs are discovered, developed, and made available. We have created a structured program with interactive opportunities, expert presentations, panel discussions, case studies, simulations, and deliberate dialogues. Patient advocates and other stakeholders will engage as equal partners in exploration, discovery, and creation of roles as leaders in a variety of patient partner situations .
When? From September 18, 2020 (includes a year-end holiday break) to February 5, 2021
For more information: Patient Partners Leadership Training Overview
Registration: Spots are limited and will be accepted to ensure a variety of affiliations and perspectives. To register, please submit an application through this link.